Company Expands Commitment to Standards


CLEVELAND [February 5] /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced Chris Wilke, DATATRAK’s Chief Technology Officer, was elected as the CDISC Advisory Board’s (CAB) Chair-Elect. 


“We are very pleased to have Chris Wilke as a member of the CDISC Advisory Board’s leadership team. His many years of industry experience will add immense value to this group and will further promote our vision to inform patient care and safety through higher quality medical research," said Dr. Rebecca Kush, President and CEO, CDISC.


“Standards are key to effective sharing of clinical research data and ultimately, improving patient health,” stated Chris Wilke, DATATRAK’s CTO.  “After serving as a member of the Advisory Board for two years, I am excited to take a more active role in furthering CDISC’s mission to develop and support global, platform-independent data standards.”


As a Charter Platinum Member of CDISC, DATATRAK has a long history of supporting CDISC and its mission to define and implement standards industry-wide.  The Company currently holds CDISC Registered Solution Provider (RSP) status in the following categories:
• CDASH
• Define.XML
• LAB
• Operational Data Model
• Study Data Tabulation Model


About DATATRAK
DATATRAK is the leader of unified eClinical® technologies and related services for the clinical trials industry.  Using the DATATRAK ONE™ multi-product, cloud-based clinical research platform, DATATRAK’s Clinical and Consulting Services™ group assists clients in conducting Phase I-IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management’s expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements.  For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company’s report filed with the OTCQX Market on November 14, 2012 announcing its results for the three-month period ending September 30, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.


Contact:
Lisa Pahl, Sr. Director Marketing, DATATRAK International, Inc., +1-979-393-9025A


Grafico Azioni DataTRAK (PK) (USOTC:DTRK)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di DataTRAK (PK)
Grafico Azioni DataTRAK (PK) (USOTC:DTRK)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di DataTRAK (PK)